Henry M. Sobell completed his studies at Brooklyn Technical High School (1948-1952), Columbia College (1952-1956), and the University of Virginia School of Medicine (1956-1960). Instead of practicing clinical medicine, he then went to the Massachusetts Institute of Technology (MIT) to join Professor Alexander Rich in the Department of Biology (1960-1965), where, as a Helen Hay Whitney Postdoctoral Fellow, he learned the technique of single crystal X-ray analysis. He then joined the Chemistry Department at the University of Rochester, having been subsequently jointly appointed to both the Chemistry and Molecular Biophysics departments (the latter at the University of Rochester School of Medicine and Dentistry), becoming a full tenured Professor in both departments (1965-1993). He is now retired and living in the Adirondacks in New York, USA.
Dr. Brij. M. Gandhi, M.Sc.(Biochemistry) and Ph.D.(Experimental Medicine, Norway) is presently CEO and founder of Neo BioMed Services (www.neobiomed.com), providing services and consultancy in health areas and regulatory issues related to biopharmaceuticals, pharmaceuticals, including stem cell and regenerative medicine. As Adviser to the Government of India, Dr. Gandhi was involved in management, promotion and policy issues in biotechnology related to international collaborations, medical biotechnology including stem cells and regenerative medicine, infrastructure development, animals and aquaculture biotechnology, biosafety and biosecurity. Prior to that he was Research Scientist at AIIMS, New Delhi working on immunology of parasitic, bacterial and viral infections including amoebic diseases; hepatitis; liver diseases; IVD; food and nutritional health issues.
Dr. Gandhi was trained at MIT, USA; LSHTM, London, NIH, USA, Hvidovre Hospital, Copenhagen and University of Bergan, Norway. Dr. Gandhi continues to serve as Advisor / Director to a number of institutions/pharma and biopharma industries with an experience of about 50 years as research scientist, science manager, adviser/consultant and having over 155 publications.
Dr. Brij M. Gandhi(Research Area)
Biopharmaceuticals, Pharmaceuticals, Stem cell and Regenerative medicine
David Perahia is an Emeritus Research Director in CNRS. He is a researcher in Laboratory of Biology and Applied Pharmacology and is associated with the team of Dynamics of Macromolecular Complexes. They LBPA conduct research in the field of anti-tumor and antiviral pharmacology and the study of pathogenic bacteria.
David Perahia (Research Area)
He is actively involved in the development of new methods enabling the study of large scale conformational changes in proteins playing an important role in their function (stability, enzymatic activity, ligand binding, protein-protein complex formation, etc.).
Boris Y. Zaslavsky is cofounder and Chief Scientific Officer of Cleveland Diagnostics from 2013. During 1997-2013 he was cofounder and Vice President of Analiza, Inc. in Cleveland. He received and M.S. from Moscow State University in 1967, Ph.D. in Bioanalytical Chemistry in 1972, and D.Sc. in 1986 from USSR Academy of Sciences. Author of a monograph and over 135 publications in peer-reviewed journals.
Boris Y. Zaslavsky (Research Area)
His research interests includes . Structural protein biomarkers, protein-solvent interactions, Fluid Mechanics, Chromatography, Polymerization, Hydrophobicity & many more.
Pascal Demange is a Research Director in the Institute of Pharmacology and Structural Biology, CNRS. The primary objective of the institute is the identification and characterization of novel therapeutic targets in the fields of cancer and infectious diseases (tuberculosis).
Pascal Demange (Research Area)
Proteins, Nuclear Magnetic Resonance, Protein Structure, Structural Biology, Structural Bioinformatics & Protein Design are some of his area of interest.
Likai Du has completed his PhD at the age of 28 years from Shandong University and works at QIBEBT, CAS between 2013-2015. In 2016, he visit National Chiao Tung University as a visit scholar. Currently, he works as an associated professor in the college of Informatics, Huazhong Agricultural University. He is focusing on the applications of the high performance computing and big data technology in theoretical chemistry/biology. He has published more than 35 papers in reputed journals and has been serving as reviewers for a series of journals, such as Chem Commun, JPC A/B/C/L, PCCP etc.
Likai Du(Research Area)
He has interests in areas such as Molecular Dynamics, Computational Photochemistry, Chemical Databases & Bioinformatics.
Sergey Suchkov was born in the City of Astrakhan, Russia, in a family of dynasty medical doctors.
In 1980, graduated from Astrakhan State Medical University and was awarded with MD. In 1985, maintained his PhD as a PhD student of the I.M. Sechenov Moscow Medical Academy and Institute of Medical Enzymology, USSR Academy of Medical Sciences, Moscow, Russia. In 2001, finished the PostDoc Research Fellowship Program and maintained his Doctor Degree at the National Institute of Immunology, Russia.
Dr. Sergey Suchkov(Research Area)
Biomarkers,Personalized Medicine,Medicine & Immunology,Translational Medicine
Dr. Bolshoy has completed his PhD from the Weizmann Institute of Science in 1993. He is an in the Department of Evolutionary and Environmental Biology, University of Haifa, Israel since 1998 and in the College of Law & Business, Ramat-Gan, Israel since 2018. He is the author of the book "Genome Clustering: from linguistics models to classification of genetic texts", Springer-Verlag, 2010, and many scientific articles. He is serving as an editorial member of several reputed journals like Bioinformatics and Biology Insights, Computational Biology and Chemistry, ISRN Bioinformatics; and Linguistic Frontiers.